Are you a new member? Sign up now
Login area
| Sign up
close
HYRIMOZ - 40mg - 2
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AB04 | BioTech | Adalimumab - 40mg | 9749 | 41119/1 | HYRIMOZ | 40mg | 2 | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Sandoz GmbH, (Schaftenau) | Austria | 1,029,343 L.L | 10.71 | E1 | Sandoz GmbH, Kundl | Austria | 2/1/2023 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AB04 | BioTech | Adalimumab - 40mg/0.4ml | 9597 | 135418/1 | HUMIRA | 40mg/0.4ml | 2 x 0.4ml | Injectable solution | SC | Interpharma S.A.L. | Vetter Pharma- Fertigung GmbH & Co KG | Germany | 304,414 L.L | 10.71 | E1 | Abbvie Deutschland GmbH & Co KG | Germany | 2/1/2023 |
| L04AB04 | BioTech | Adalimumab - 40mg/0.8ml | 9616 | 149418/1 | AMGEVITA | 40mg/0.8ml | 2 x 0.8ml | Injectable solution | SC | Mersaco | Amgen Manufacturing Ltd | USA | 796,876 L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 2/1/2023 |
| L04AB04 | BioTech | Adalimumab - 40mg/0.8ml | 9617 | 149318/1 | AMGEVITA | 40mg/0.8ml | 2 x 0.8ml | Injectable solution | SC | Mersaco | Amgen Manufacturing Ltd | USA | 1,377,776 L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 2/1/2023 |
| L04AB04 | BioTech | Adalimumab - 40mg | 9748 | 41219/1 | HYRIMOZ | 40mg | 2 | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Sandoz GmbH, (Schaftenau) | Austria | 734,991 L.L | 10.71 | E1 | Sandoz GmbH, Kundl | Austria | 2/1/2023 |
| L04AB04 | BioTech | Adalimumab - 40mg/0.8ml | 10085 | 125519/1 | CINNORA | 40mg/0.8ml | 2 | Injectable solution | SC | Lebiran SARL | Cinnagen Co | Iran | 2,561,387 L.L | 19.35 | D | Cinnagen Co | Iran | 2/1/2023 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2023